INFOSYS Q1 : CONS. NET PROFIT DOWN 5.7 % AT 5360 CR (QOQ), UP 3 % (YOY)
REVENUE UP 9.4 % AT 34470 CR (QOQ) , UP 23 % (YOY)
EBIT DOWN 0.6 % AT 6914 CR (QOQ), UP 4.7 % (YOY)
MARGINS AT 20.1 % V 21.5 % (QOQ), 23.7 % (YOY)
INFOSYS Q1 : Revenues in CC terms grew by 21.4% YoY and 5.5% QoQ
INFOSYS: ARTRITION RATE AT 28.8 % V 27.7 % (QOQ)
Infosys: FY 23 Revenue guidance increased to 14%-16%. Margin guidance retained at 21%-23%
REVENUE UP 9.4 % AT 34470 CR (QOQ) , UP 23 % (YOY)
EBIT DOWN 0.6 % AT 6914 CR (QOQ), UP 4.7 % (YOY)
MARGINS AT 20.1 % V 21.5 % (QOQ), 23.7 % (YOY)
INFOSYS Q1 : Revenues in CC terms grew by 21.4% YoY and 5.5% QoQ
INFOSYS: ARTRITION RATE AT 28.8 % V 27.7 % (QOQ)
Infosys: FY 23 Revenue guidance increased to 14%-16%. Margin guidance retained at 21%-23%
STEEL EXCHANGE Q1 : NET PROFIT UP 2 % AT 8.12 CR (YOY), DOWN 93 % (QOQ)
REVENUE UP 37 % AT 360 CR (YOY), DOWN 1.5 % (QOQ)
EBITDA UP 15 % AT 34 CR (YOY), UP 19.5 % (QOQ)
MARGINS AT 9.5 % V 11.4 % (YOY), 7.8 % (QOQ)
REVENUE UP 37 % AT 360 CR (YOY), DOWN 1.5 % (QOQ)
EBITDA UP 15 % AT 34 CR (YOY), UP 19.5 % (QOQ)
MARGINS AT 9.5 % V 11.4 % (YOY), 7.8 % (QOQ)
NAVIN FLOURINE Q1 : CONS. NET PROFIT UP 32 % AT 74 CR (YOY), DOWN 1 %(QOQ)
REVENUE UP 22 % AT 398 CR (YOY), DOWN 3 % (QOQ)
EBITDA UP 27 % AT 99.1 CR (YOY) , UP 5.9 % (QOQ)
MARGINS AT 24.9 % V 23.8 % (YOY), 23 % (QOQ)
Good Results 👍
REVENUE UP 22 % AT 398 CR (YOY), DOWN 3 % (QOQ)
EBITDA UP 27 % AT 99.1 CR (YOY) , UP 5.9 % (QOQ)
MARGINS AT 24.9 % V 23.8 % (YOY), 23 % (QOQ)
Good Results 👍
TATA STEEL Q1 : CONS. NET PROFIT DOWN 13 % AT 7760 CR (YOY), DOWN 20 % (QOQ)
REVENUE UP 18.5 % AT 63430 CR (YOY) ,DOWN 8.5 % (QOQ)
EBITDA DOWN 7 % AT 14972 CR (YOY), FLAT (QOQ)
MARGINS AT 23.6 % V 30.1 % (YOY), 21.67 % (QOQ)
Results are not so bad ✏🗒
REVENUE UP 18.5 % AT 63430 CR (YOY) ,DOWN 8.5 % (QOQ)
EBITDA DOWN 7 % AT 14972 CR (YOY), FLAT (QOQ)
MARGINS AT 23.6 % V 30.1 % (YOY), 21.67 % (QOQ)
Results are not so bad ✏🗒
Stocks in News : 26 Jul 2022
Tata Motors: The company signed a memorandum of understanding with EC Wheels India, an app based urban transportation service in Kolkata to deploy 1,000 XPRES T Electric sedans for cab transportation.
Bajaj Finserv: The company will consider proposals for bonus issue and sub-division of shares on July 28.
Larsen & Toubro: The company issued a clarification of media reports suggesting sale of block of roads and transmission project to Edelweiss fund for Rs 7,000 crore. It said that it has not signed any such agreement for sale.
Sonata Software: The company approved issue of one bonus share for every three shares.
Lupin: The company received approval from the U.S. FDA for Abbreviated New Drug Application, Azilsartan Medoxomil tablets, 40 mg and 80 mg, to market a generic equivalent of Edarbi tablets of Azurity Pharmaceuticals, Inc. The product will be manufactured at the company’s facility in Nagpur.
PSP Projects: The company received orders worth Rs 257.27 crore including two work orders from repeat clients i.e. Development of Ahmedabad Airport in Institutional segment and one Pharmaceutical Project in Industrial segments worth Rs 128.01 crores and Rs 98.99 crores respectively and remaining orders worth Rs 30.26 crores are from the Precast segment.
Tata Motors: The company signed a memorandum of understanding with EC Wheels India, an app based urban transportation service in Kolkata to deploy 1,000 XPRES T Electric sedans for cab transportation.
Bajaj Finserv: The company will consider proposals for bonus issue and sub-division of shares on July 28.
Larsen & Toubro: The company issued a clarification of media reports suggesting sale of block of roads and transmission project to Edelweiss fund for Rs 7,000 crore. It said that it has not signed any such agreement for sale.
Sonata Software: The company approved issue of one bonus share for every three shares.
Lupin: The company received approval from the U.S. FDA for Abbreviated New Drug Application, Azilsartan Medoxomil tablets, 40 mg and 80 mg, to market a generic equivalent of Edarbi tablets of Azurity Pharmaceuticals, Inc. The product will be manufactured at the company’s facility in Nagpur.
PSP Projects: The company received orders worth Rs 257.27 crore including two work orders from repeat clients i.e. Development of Ahmedabad Airport in Institutional segment and one Pharmaceutical Project in Industrial segments worth Rs 128.01 crores and Rs 98.99 crores respectively and remaining orders worth Rs 30.26 crores are from the Precast segment.
L&T Q1 : CONS. NET PROFIT UP 45 % AT 1703 CR (YOY), DOWN 53 % (QOQ)
REVENUE UP 22 % AT 35853 CR (YOY), DOWN 32 % (QOQ)
EBITDA UP 25 % AT 3957 CR (YOY), DOWN 40 % (QOQ)
MARGINS AT 11.03 % V 10.8 % (YOY), 12.3 % (QOQ)
LT rising due to good Q1 results
REVENUE UP 22 % AT 35853 CR (YOY), DOWN 32 % (QOQ)
EBITDA UP 25 % AT 3957 CR (YOY), DOWN 40 % (QOQ)
MARGINS AT 11.03 % V 10.8 % (YOY), 12.3 % (QOQ)
LT rising due to good Q1 results
L&T Review
Jefferies
Buy, TP Rs 2215
1Q rev & EBITDA 11% & 10% above expectations
Order flow growth strong at 57% YoY growth, driven by both domestic & intl segments
Management maintained its 12-15% YoY order flow & rev growth guidance
Jefferies
Buy, TP Rs 2215
1Q rev & EBITDA 11% & 10% above expectations
Order flow growth strong at 57% YoY growth, driven by both domestic & intl segments
Management maintained its 12-15% YoY order flow & rev growth guidance
*Tata Motors Ltd.* | *CMP* Rs. 458 | *M Cap* Rs. 152214 Cr | *52 W H/L* 537/268
*Result below Expectation*
Revenue from Operations came at Rs. 71934.7 Cr (-8.3% QoQ, 8.3% YoY) vs expectation of Rs. 71509.7 Cr, QoQ Rs. 78439.1 Cr, YoY Rs. 66406.5 Cr
EBIDTA came at Rs. 3180.5 Cr (-63.6% QoQ, -39.5% YoY) vs expectation of Rs. 6608.5 Cr, QoQ Rs. 8727.1 Cr, YoY Rs. 5257.6 Cr
Lower EBITDA is on account of £(236)m (Rs.2153cr) FX and commodity revaluation
EBITDA Margin came at 4.4% vs expectation of 9.2%, QoQ 11.1%, YoY 7.9%
Adj. PAT came at Rs. -6500.2 Cr vs expectation of Rs. -1039.6 Cr, QoQ Rs. -319 Cr, YoY Rs. -4453.4 Cr
Quarter EPS is Rs. -19.6
Stock is trading at P/E of 11.6x FY24E EPS
*Result below Expectation*
Revenue from Operations came at Rs. 71934.7 Cr (-8.3% QoQ, 8.3% YoY) vs expectation of Rs. 71509.7 Cr, QoQ Rs. 78439.1 Cr, YoY Rs. 66406.5 Cr
EBIDTA came at Rs. 3180.5 Cr (-63.6% QoQ, -39.5% YoY) vs expectation of Rs. 6608.5 Cr, QoQ Rs. 8727.1 Cr, YoY Rs. 5257.6 Cr
Lower EBITDA is on account of £(236)m (Rs.2153cr) FX and commodity revaluation
EBITDA Margin came at 4.4% vs expectation of 9.2%, QoQ 11.1%, YoY 7.9%
Adj. PAT came at Rs. -6500.2 Cr vs expectation of Rs. -1039.6 Cr, QoQ Rs. -319 Cr, YoY Rs. -4453.4 Cr
Quarter EPS is Rs. -19.6
Stock is trading at P/E of 11.6x FY24E EPS
Two things only stands for “B” Bitcoin & Bull 🦬 🏃♂️ 🏃♀️ 🏃♂️ 🏃♀️ 🏃♂️ 🏃♀️
MRPL Q1 : ST. NET PROFIT OF 2708 CR V 119 CR LOSS (YOY), DOWN 10 % (QOQ)
REVENUE UP 138 % AT 35915 CR (YOY), UP 27 % (QOQ)
EBITDA AT 4713 CR V 283 CR PROFIT (YOY), UP 60 % (QOQ)
MARGINS AT 13.1 % V 1.8 % (YOY), 10.4 % (QOQ)
Beneficiary of Crude prices.
WELSPUN ENT. Q1 : CONS. NET PROFIT UP 91 % AT 48 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 105 % AT 763 CR (YOY), UP 57 % (QOQ)
EBITDA UP 170 % AT 90 CR (YOY), UP 20 % (QOQ)
MARGINS AT 11.8 % V 8.97 % (YOY), 15.5 % (QOQ)
NIPPON LIFE Q1 : CONS NET PROFIT DOWN 35% AT 114CR (QOQ), 37% (YOY)
REVENUE DOWN 6% AT 316CR (QOQ) , UP 5% (YOY)
EBIT DOWN 14% AT 179CR (QOQ) UP 1% (YOY)
MARGINS 56.6% V 61.5% (QOQ) 58.6% (YOY)
Poor results
REVENUE UP 138 % AT 35915 CR (YOY), UP 27 % (QOQ)
EBITDA AT 4713 CR V 283 CR PROFIT (YOY), UP 60 % (QOQ)
MARGINS AT 13.1 % V 1.8 % (YOY), 10.4 % (QOQ)
Beneficiary of Crude prices.
WELSPUN ENT. Q1 : CONS. NET PROFIT UP 91 % AT 48 CR (YOY), DOWN 25 % (QOQ)
REVENUE UP 105 % AT 763 CR (YOY), UP 57 % (QOQ)
EBITDA UP 170 % AT 90 CR (YOY), UP 20 % (QOQ)
MARGINS AT 11.8 % V 8.97 % (YOY), 15.5 % (QOQ)
NIPPON LIFE Q1 : CONS NET PROFIT DOWN 35% AT 114CR (QOQ), 37% (YOY)
REVENUE DOWN 6% AT 316CR (QOQ) , UP 5% (YOY)
EBIT DOWN 14% AT 179CR (QOQ) UP 1% (YOY)
MARGINS 56.6% V 61.5% (QOQ) 58.6% (YOY)
Poor results